← Open Payments lookup

OPEYEMI BELLO: Open Payments

NPI 1023497351 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$491 in 13 payments from 8 companies in 2025. Trend: 2023 $45 · 2024 $259 · 2025 $491

Food & beverage: $491
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.3$171
Otsuka America Pharmaceutical, Inc.1$125
Lundbeck LLC3$62
Teva Pharmaceuticals USA, Inc.2$43
E.R. Squibb & Sons, L.L.C.1$31
Alkermes, Inc.1$25
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21
Supernus Pharmaceuticals, Inc.1$14

Products named: INGREZZA, ABILIFY MAINTENA, UZEDY, REXULTI, COBENFY, ARISTADA, CAPLYTA, ABILIFY ASIMTUFII.

Industry payments across CA — which companies pay providers there.